Altimmune, Inc. (ALT)
3.15
-0.05
(-1.56%)
USD |
NASDAQ |
Aug 26, 16:00
3.16
+0.01
(+0.32%)
After-Hours: 20:00
Altimmune Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.00% |
| September 30, 2025 | -440.0% |
| June 30, 2025 | -500.0% |
| March 31, 2025 | -480.0% |
| December 31, 2024 | -560.0% |
| September 30, 2024 | -640.0% |
| June 30, 2024 | -1.12K% |
| March 31, 2024 | -2.04K% |
| December 31, 2023 | -5.01K% |
| September 30, 2023 | 0.00% |
| June 30, 2023 | 0.00% |
| March 31, 2023 | |
| December 31, 2022 | 0.00% |
| September 30, 2022 | 0.00% |
| June 30, 2022 | -562.5% |
| March 31, 2022 | -271.9% |
| December 31, 2021 | 89.89% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 99.48% |
| December 31, 2014 | 97.99% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
| December 31, 2013 | 0.00% |
| September 30, 2013 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 72.08% |
| Protalix Biotherapeutics, Inc. | 60.99% |
| Taysha Gene Therapies, Inc. | -- |
| Humacyte, Inc. | -423.2% |
| Liquidia Corp. | 93.10% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -34.49% |
| Return on Assets | -29.57% |
| Return on Invested Capital | -31.22% |
| Return on Net Operating Assets | -5.10K% |